Application no. and date | 03796412.9 (espacenet) (Federated) (European Patent Register), 20031117 | Patent/reg. no. and date | DK/EP 1576138, 20170201 | Publication date | 20050921 | Priority no. and date | US 426675 P, 20021115 | EP pub. no. and date |
EP 1576138 20050921 | Effective date | | Applicant/owner | UNIVERSITA DEGLI STUDI DI CAGLIARI, Via Università 40
09124 Cagliari, IT, Idenix Pharmaceuticals LLC., 320 Bent Street, Floor 4
Cambridge, MA 02141, US | Applicant ref. no. | P61427DK01 | Inventor | STANDRING, David, 205 Gun Hill St
Milton, MA 02186, US, SOMMADOSSI, Jean-Pierre, 7 Lowell Street
Cambridge, MA 02138, US, LA COLLA, Paolo, 5 Strada no. 11, Poggio dei Pini
I-09012 Capoterra, Cagliari, IT, BICHKO, Vadim, 23 Clarendon Road
Belmont, MA 02478, US, QU, Lin, 308 Boston Avenue, Apt. 37
Medford, MA 02115, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/7052 (2006.01) , A61K 38/21 (2006.01) , A61P 31/18 (2006.01) , C12Q 1/04 (2006.01) , C12Q 1/70 (2006.01) | Title | 2'-METHYLNUKLEOSIDER I KOMBINATION MED INTERFERON OG FLAVIVIRIDAE-MUTATION | Int. application no. | US2003036714 | Int. publication no. | WO2004046331 | Related patent (certificate) | | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|